glp-1 medications lean muscle retention weight loss with medicines does not result in a disproportionate loss of mass or function in obese mice and humans: Cell Reports Medicine GLP-1 and Muscle Loss: Semaglutide,

The incidence rate was however very small, meaning that any direct causality is hard to pin down

The FDA notice cites several possible medical uses for the substances, such as using BPC-157 to treat ulcerative colitis

For instance, antioxidant supplementation in women with unexplained subfertility has not shown significant changes in age, BMI, basal FSH, mature MII oocyte count, or clinical pregnancy rate

Tiny samples

Cysteine dioxygenase 1 (CDO1) plays an important role in Erastin-induced ferroptosis in GC cells (Hao et al., 2017)

Some people report weight loss, but there is limited clinical evidence to support microdosing as an effective long-term weight management strategy